Amesite (AMST) Stock Explodes 190% on Breakthrough Healthcare AI Contract

Key Highlights

• Shares of Amesite (AMST) climbed 190% during premarket hours on Tuesday following announcement of a major enterprise contract.
• The new client will implement NurseMagic AI documentation technology for a workforce managing roughly 2,700 patients.
• System integration will include connections to electronic medical records (EMR) and electronic visit verification (EVV) platforms.
• Implementation aims to slash documentation time for caregivers by as much as 16 hours weekly per employee.
• Company has successfully reduced operational expenses by 18% across the previous six quarters.

On May 18, 2026, Amesite Inc. revealed it had signed a major home care enterprise client for its NurseMagic AI-powered documentation solution — representing the company’s biggest customer acquisition to date. The announcement triggered a dramatic 190% surge in AMST shares during premarket trading Tuesday morning.

Amesite Inc., AMST

The newly acquired enterprise client manages care for approximately 2,700 patients and plans to deploy NurseMagic throughout its entire workforce. Integration will encompass both electronic medical record infrastructure and electronic visit verification platforms.

The primary value proposition centers on dramatic time efficiency gains. Currently, documentation tasks consume up to 16 hours weekly for each caregiver, and NurseMagic’s AI-driven approach is engineered to dramatically reduce this administrative load.

The implementation accommodates multiple user types, hierarchical permission structures, and customized documentation workflows spanning thousands of patient records — all without the protracted onboarding timeline that Amesite claims can extend for weeks or months with conventional systems.

Financial Performance Reflects Strategic Cost Management

This major contract announcement arrives as Amesite has been implementing disciplined cost reduction measures. Sarah Berman, Principal Finance and Accounting Officer, highlighted approximately 18% in operational spending cuts across the last six quarters, achieved while simultaneously expanding the company’s paying customer base.

This combination of efficiency improvements and customer growth represents a notable achievement for a micro-cap equity. Amesite maintains a market capitalization of approximately $4.48 million, making any substantial enterprise contract financially significant.

Madison Bush, Director of Corporate Operations, shared that the company’s sales and marketing initiatives are driving approximately 4,200 daily website visits. She further revealed that more than 70% of qualified prospects currently in discussions have independently scheduled product demonstrations via the company website.

Robust Sales Pipeline Suggests Future Growth

Beyond this latest implementation, Amesite indicates it maintains active negotiations with multiple additional organizations that collectively represent several thousand more patients. The company has not disclosed specific prospect names or projected closing timelines.

NurseMagic currently operates across more than 100 healthcare professions throughout all 50 states and 21 countries worldwide. The platform features multilingual support and maintains full HIPAA compliance.

The stock maintains average daily trading volume near 682,000 shares. Technical analysis sentiment for the equity was previously rated as a sell, though this assessment predated Tuesday’s major announcement.

The 2,700-patient contract represents the company’s largest client win and, according to executive leadership, signals NurseMagic’s evolution from a supplementary assistance tool into what management characterizes as essential clinical infrastructure within the non-acute healthcare sector.

The post Amesite (AMST) Stock Explodes 190% on Breakthrough Healthcare AI Contract appeared first on Blockonomi.